Broad-Based Growth Arrives, Incrementals Compress, and the Re-Rating Outruns the Raise

Results vs. Consensus

Parker reported fiscal 2026 second-quarter results before the open on January 29, with the call at 11:00 a.m. ET. It was a beat on every line the Street tracks and, for the second consecutive quarter, a wider beat against the framework the company itself had laid out three months earlier.

Q2 FY26 Scorecard

A second consensus source carried adjusted EPS at $7.15 and a headline revenue figure of $5.04B, though the same source's three segment estimates sum to roughly $5.07B. The penny of spread on earnings is immaterial; on revenue we have used the tighter $5,070M figure, which the segment build corroborates. No published consensus existed on a comparable basis for segment operating margin or free cash flow, so those lines are scored against the company's own guidance below.

GAAP EPS is not a useful comparison this quarter. The December 2024 quarter carried a $250M pre-tax gain on divestitures, worth $223M after tax and $1.70 of diluted EPS. Stripping it out, the underlying GAAP trajectory moved in the same direction as the adjusted number.

Versus the Company's Own Q2 Guide

This is the comparison that carries information, because Parker guides the quarter explicitly and did so on November 6 alongside first-quarter results. Every element was cleared again, though by a narrower margin than in September.

The pattern holds and the magnitude narrows. September beat its own three-month-old plan by 10.9% on adjusted EPS; December beat by 7.7%. Both are large. The direction of the change is worth logging, because the entire November rating rested on a management team that sets its quarters conservatively and then leaves the balance of the year alone.

Year-over-Year Income Statement

Gross profit is not a line Parker reports; the figures above are net sales less cost of sales. The prior-year effective tax rate of 18.6% was depressed by the divestiture gain, which is why the 197bp increase reads worse than the underlying rate change. Management now guides the full year to 22.1% with the second half at 22.5%.

First-Half Comparison

Parker's fiscal first half is now complete, and the six-month columns are the cleanest read on the year to date because they neutralize the seasonality that makes the September and December quarters hard to compare directly.

Sequential Comparison

The December quarter is seasonally Parker's softest top line, and it was not this year. Revenue rose sequentially, organic growth accelerated, and adjusted segment margin gave back only 30bps. The line that moved is the incremental.

Revenue

The $5,174M print is a second-quarter record and the composition is the best Parker has assembled in this cycle. Reported growth of 9.1% is the net of 6.6 points of organic growth, 1.8 points of currency and 1.5 points of acquisition, less 0.8 points from divestitures. December was the final quarter carrying the divestiture drag, so reported growth optics improve again from March onward without any change in underlying demand.

The organic 6.6% is a genuine acceleration from 5.0% in September, and where it came from matters more than the level. Aerospace at 13.5% was expected. What was not was International at 4.6% with Europe turning positive at 2.1%, and North America holding 2.5% against a 2.0% guide. That combination produced the second consecutive quarter of organic growth in every reported business, and it extended into the technology platforms that sit beneath the reporting lines.

"Sales were up 9% versus prior. Organic growth was positive at nearly 7%. Currency was favorable 2%. Acquisitions were favorable by 1.5%, and divestitures were a 1% headwind. Just to note, it's been now 12 months since we've completed those divestitures. This was the last quarter, then we will have a divestiture adjustment going forward."
— Todd Leombruno, Chief Financial Officer

Margins

Adjusted segment operating margin of 27.1% expanded 150bps year over year, and each of the three businesses again set a record: North America 25.4% (up 80bps), International 26.0% (up 190bps), Aerospace 30.2% (up 200bps). Three simultaneous records for a second consecutive quarter is difficult to explain as portfolio mix. It is an operating result.

Below the segment line the arithmetic is equally clean. Gross margin expanded 103bps to 37.3%, SG&A fell 31bps as a share of sales, and corporate general and administrative expense declined in dollars to $53M on 9.1% more revenue. Adjusted EBITDA margin reached 27.7%, up 90bps. The only meaningful non-operating drag was the $252M year-over-year swing in other income, which is the divestiture gain rolling off rather than a deterioration in the underlying business.

The sequential detail worth flagging is North America at 25.4% against 27.0% in September, a 160bp step down. Management attributed it entirely to mix and reiterated the full-year path.

"So there's nothing about the North American margin other than Q2 mix was not as favorable as Q1. That's all that's there. Listen, Q2 is a record for us, 80 basis points of margin expansion, 52% incrementals. The team is performing very well."
— Jennifer Parmentier, Chairman and Chief Executive Officer

EPS

Adjusted EPS of $7.65 grew 17.2% on 9.1% revenue growth. Management's own bridge does the work: segment operating income contributed $1.15, share count $0.16, and corporate G&A plus income tax roughly a further cent, against $0.18 of drag from other expense and $0.03 from interest. Segment operations alone therefore contributed more than the entire $1.12 of net growth, with buyback adding $0.16 and below-the-line items subtracting $0.20 on a net basis.

That is a higher-quality mix than September, when operations carried about 78% of the growth and the tax rate was a $0.16 headwind. It is also the second consecutive quarter in which the share-count contribution has been meaningful. The forward question, addressed below, is whether it stays that way with $9.25 billion of acquisition consideration to fund.

Segment Performance

Parker reports two segments, Diversified Industrial and Aerospace Systems, and splits the industrial segment into North America and International businesses for revenue and margin disclosure. Aerospace is now 33.0% of company revenue, up from 31.4% a year ago, and 36.7% of adjusted segment operating income.

Orders and Backlog

Orders are the leading indicator that separates a good print from an inflection, and the December quarter widened the gap between what Parker is booking and what it is shipping. Company orders reached 9% with every reported business positive for a second consecutive quarter, and total backlog set another record.

Industrial order comparisons are three-month averages at constant currency excluding divestitures; Aerospace comparisons are rolling twelve-month averages. With Aerospace backlog disclosed at a record $8 billion against a company total of $11.7 billion, the industrial book sits around $3.7 billion, and management confirmed it grew sequentially for the first time in this cycle.

Diversified Industrial, North America

Sales of $1,986M grew 3.0% reported and 2.5% organically, ahead of the 2.0% management guided in November. Adjusted segment operating margin reached a record 25.4%, up 80bps, on 52% incrementals. Order rates were the headline: they jumped from 3% to 7%, the sharpest acceleration Parker disclosed this quarter.

"And orders in North America took a big jump and increase to plus 7% compared to the prior year. And a notable driver there were a few multiyear aerospace and defense orders within those North American businesses."
— Todd Leombruno, Chief Financial Officer

Management was candid that the order jump was not evenly sourced, and volunteered the breadth question before it was asked twice.

"So definitely, it wasn't all aerospace and defense, but there were some multiyear aerospace and defense orders that hit our industrial businesses that really caused that jump from 3% to 7%. But positive orders and implant off-highway and energy."
— Jennifer Parmentier, Chairman and Chief Executive Officer

Assessment: The organic beat is small (50bps) and the margin is a record, but the order print is the material item and it is partly a long-cycle defense booking that converts over years rather than quarters. Management raised the full-year North American organic assumption only to 2.5%, and guided the second half margin to about 26.5%. The pattern from September repeats: the results improve, the plan follows at half the pace. The difference this quarter is that the plan is now closer to the results, which removes some of the upside we were underwriting.

Diversified Industrial, International

Sales of $1,482M grew 11.8% reported and 4.6% organically, with 4.7 points of currency and 2.5 points of acquisition. This was the segment's best organic quarter of the cycle and the first with Europe positive.

"In Asia Pac, organic growth was the strongest at plus 9%. And Europe turned positive in the quarter to plus 2%. We were really glad to see Europe turn positive."
— Todd Leombruno, Chief Financial Officer

Adjusted margin reached a record 26.0%, up 190bps, which management attributed to productivity gains and operational execution rather than volume. The full-year International organic assumption doubled to 2% from 1%, with EMEA raised to low single digit from flat and Asia Pacific to positive mid single digit from positive low single digit.

Management was immediately clear that the quarter was flattered.

"So international, we are increasing full year organic growth to 2%, and that was previously 1%. So they did have a fantastic Q2. This was primarily from some large project shipments that went out, which really helped them."
— Jennifer Parmentier, Chairman and Chief Executive Officer

Assessment: Europe turning positive is the single most durable improvement in the print, because it removes the one region that had been actively subtracting. But 4.6% organic is not the run rate: management guided March back to 2% and named the reason, which is power generation and commercial HVAC filtration project shipments in EMEA that do not repeat. The honest read is that International has stopped being a drag and has not yet become a driver. The 6% order rate, unchanged from September, is consistent with that.

Aerospace Systems

Sales of $1,706M grew 14.5% reported and 13.5% organically, a twelfth consecutive quarter of double-digit organic growth. Commercial original equipment grew 26% and commercial aftermarket 17%. Adjusted segment operating margin reached a record 30.2%, up 200bps, and backlog crossed $8 billion for the first time in the company's history, up 14%.

"Order rates remain impressive in Aerospace at plus 14%. Backlog also increased plus 14% and reached a record $8 billion for Aerospace for the first time in the history of the company."
— Todd Leombruno, Chief Financial Officer

Management raised the full-year Aerospace organic growth guide to 11% from 9.5%, and lifted the sub-market assumptions underneath it: commercial original equipment to roughly 20% from mid-teens, and commercial aftermarket to low double digit from high single digit. Defense original equipment was maintained at roughly mid single digit and defense aftermarket was trimmed to low single digit from mid single digit.

Assessment: This is the second consecutive quarter in which the structurally lower-margin half of Aerospace grew fastest and margin still set a record, and the second in which management pointed to spares timing as the reason the print exceeded the guide. At some point a recurring explanation for recurring outperformance stops being an explanation. Commercial original equipment at 26% with margin up 200bps says the cost position moved. The second-half guide of roughly 29.5% embeds a step down that has now failed to materialize twice.

Key KPIs

Key Topics & Management Commentary

Overall Management Tone: Management was assured and specific, presenting a print in which every reported business grew organically and every business set a margin record, and treating the Filtration Group acquisition as an integration exercise already under way rather than a deal still to be defended. The posture was more relaxed than at the November call, where the dominant question was why the guide would not extrapolate the quarter; this time the plan moved with the results and the pushback shifted to duration and to the shape of the fourth quarter. Where the call was least forthcoming was on capital structure: a $9.25 billion cash acquisition and $7.75 billion of committed term loans drew no question on leverage, financing cost, or the buyback.

1. Organic Growth Broadens Beneath the Reporting Lines

The headline is that every reported business grew organically for a second consecutive quarter. The more informative disclosure came in the first question, which pointed out that all three Diversified Industrial technology platforms (motion systems, flow and process control, and filtration and engineered materials) grew organically together for the first time since the June 2023 quarter. Management confirmed it and attributed the turn to a mix of company-specific and cyclical factors.

"I would say that it's a combination of what we're seeing in some of our short-cycle businesses that we've pointed out. While all of them are not returning to positive growth, we did see some nice improvement in off-highway. And then I would say the aerospace business that sits inside of these industrial businesses is performing very well."
— Jennifer Parmentier, Chairman and Chief Executive Officer

The single most useful demand datapoint was volunteered in the same answer: "Our distribution did have low single-digit organic growth in the quarter." Parker's distribution channel is the short-cycle proxy, and in November management described channel inventory as at a trough with no restocking observed. Distribution growing organically is the first evidence that the trough has ended.

Assessment: Breadth is the change this quarter, not level. A recovery that shows up in one segment is noise; one that shows up in three technology platforms and the distribution channel simultaneously is a cycle. This confirms the industrial inflection pillar we established in November. It also, unhelpfully for the rating, means the inflection is now visible to everyone rather than only to those reading the order book.

2. Aerospace Holds Above 30% and the Full-Year Guide Goes to 11%

Aerospace Systems delivered a second consecutive quarter above a 30% adjusted segment operating margin, at 30.2%, on 13.5% organic growth and commercial original equipment growth of 26%. Backlog reached a record $8 billion.

"And lastly, Aerospace continues to perform exceptionally well. Sales for the quarter were a record $1.7 billion, that's up 14.5% versus prior year."
— Todd Leombruno, Chief Financial Officer

The full-year organic guide moved to 11% from 9.5%, which is the second increase this fiscal year against an initial August plan of 8%. Every commercial sub-market assumption went up; only defense aftermarket came down, from mid single digit to low single digit.

Assessment: Aerospace is doing exactly what the structural-mix pillar predicted, and it is now a third of revenue and 36.7% of adjusted segment operating income. The one item to watch is the defense aftermarket trim, which is small but is the first negative revision inside Aerospace since we initiated. The commercial side is carrying the segment entirely, and commercial cycles do not run forever.

3. Orders Reach 9% and the Industrial Backlog Finally Inflects

Company order rates reached 9% with every reported business positive, and total backlog set a record at $11.7 billion. The move underneath was in North America, which went from 3% to 7%.

"Orders were plus 9% versus prior year. And a positive note is order rates were positive in all of our reported businesses. Backlog increased to a record $11.7 billion."
— Todd Leombruno, Chief Financial Officer

The disclosure that had not previously existed is on the industrial book specifically, which had been declining while Aerospace carried the company total.

"Industrial backlog has gone up in Q2. Yes, Industrial backlog went up. It remains in the mid-20s, and it grew from Q1 to Q2."
— Jennifer Parmentier, Chairman and Chief Executive Officer

Assessment: An industrial backlog that stops shrinking is a cleaner inflection signal than an order rate, because it nets shipments against bookings. Combined with the sequential increase in the total book and a 9% order rate against a 5% organic plan, this is the strongest forward evidence in the print. The qualifier is composition: a meaningful share of the North American acceleration is multi-year aerospace and defense work booked into industrial divisions, which converts over a longer horizon than short-cycle distribution demand.

4. Europe Turns Positive and International Doubles Its Full-Year Plan

EMEA organic growth of 2.1% ended the region's run of contraction, and management raised the full-year International organic assumption to 2% from 1%, with EMEA specifically moving from flat to low single digit and Asia Pacific from positive low single digit to positive mid single digit.

The regional detail management gave was unusually granular: gradual improvement in European transportation led by trucks, continued strength in mining and energy across both oil and gas and power generation, and proposed stimulus and defense spending characterized as a long-term positive that does not affect this fiscal year.

Assessment: Europe going from a 2.6% organic decline in September to 2.1% growth in December is a 470bp swing in one quarter, and it is the reason International beat. Management immediately capped it by naming the non-repeating project shipments and guiding March back to 2%. That is the right disclosure and it is also the reason we are not extrapolating: the underlying European industrial economy improved, but not by 470bps in three months.

5. Filtration Group: $9.25 Billion, 19.6x, and a Balance Sheet That Changes Shape

Parker agreed on November 10 to acquire Filtration Group Corporation from Madison Industries for $9.25 billion in cash on a cash-free, debt-free basis. Filtration Group expects calendar 2025 sales of $2 billion at a 23.5% adjusted EBITDA margin, which puts the purchase at 19.6x estimated 2025 adjusted EBITDA before synergies and 13.4x including the $220 million of expected cost synergies. It is the largest acquisition in Parker's history by price.

"We are making continued progress on the Filtration Group acquisition. Integration planning is underway using our proven integration playbook. We expect to close in 6 to 12 months from our November announcement date."
— Jennifer Parmentier, Chairman and Chief Executive Officer

The strategic case is coherent. Filtration is one of Parker's better-margin, higher-aftermarket technology platforms, and the combination adds life sciences and HVAC/refrigeration exposure while lifting Parker Filtration aftermarket sales by 500 basis points.

"The combination of Parker Filtration and Filtration group creates one of the largest global industrial filtration businesses and increases Parker Filtration aftermarket sales by 500 basis points. We will leverage our business system, the Win Strategy to achieve approximately $220 million in cost synergies, and we expect this deal to meet our disciplined acquisition criteria of being accretive to organic growth, synergized EBITDA margin, adjusted EPS and cash flow."
— Jennifer Parmentier, Chairman and Chief Executive Officer

What did not come up on the call is the financing. On December 10, Parker arranged two committed senior unsecured delayed-draw term loan facilities totalling $7.75 billion: a $5.25 billion 364-day facility and a $2.50 billion three-year facility, with proceeds earmarked to fund a portion of the consideration. The 364-day tranche carries mandatory prepayment from the net proceeds of future debt or equity issuances and asset sales, which is the standard structure for a bridge that is expected to be taken out in the bond market.

Assessment: In November we wrote that Parker's balance-sheet capacity was "more likely to be spent on a deal than on the share count." It was, within four days of that report. The strategic logic is sound and the integration track record with CLARCOR, LORD and Meggitt supports the synergy number. But 19.6x pre-synergy is a full price paid at the top of Parker's own multiple, the deal takes pro-forma net leverage to roughly 3.0x on our estimate against a stated 2.0x target, and the balance-sheet optionality we scored as a bull pillar is now spent. What was an option is now an obligation with a February 2027 outside date.

6. The Guidance Raise and Where It Lands

Full-year adjusted EPS guidance rose to $30.70 at the midpoint from $30.00, with the range narrowing to plus or minus $0.30 from plus or minus $0.40. Adjusted segment operating margin moved to 27.0% to 27.4% from 26.8% to 27.2%, organic growth to 4% to 6% from 2.5% to 5.5%, and free cash flow to $3.2 billion to $3.6 billion.

"And finally, when we look at EPS, we're raising EPS to $30.70 at the midpoint. That's an increase of 12.3% versus prior, and the range on that adjusted EPS is plus or minus $0.30."
— Todd Leombruno, Chief Financial Officer

Of the $0.70 increase, $0.55 is the second-quarter beat against the $7.10 guided. The implied second half moved from $15.68 to $15.83, a $0.15 raise. That is more than the seven cents the second half moved in November, and it is still the overwhelming majority of the raise coming from a quarter already banked.

Assessment: The guidance behaviour is unchanged and the interpretation has shifted. In November, a company that would not extrapolate an 11% beat was offering information about its own conservatism, and that conservatism was the asymmetry we underwrote. This quarter management did raise the underlying revenue assumptions across every vertical and business, which means the revenue conservatism has been partly spent. What remains conservative is the margin, and management explicitly told us why it will not extend: second-half incrementals are guided to 35%.

7. Incremental Margins Compress from 73% to 44%, and the Second Half Is Guided to the Model

Adjusted segment operating income rose $191M on $431M of reported revenue growth, a 44% reported incremental against 73% in September. North America converted at 52%. The full-year assumption is unchanged at roughly 40%, which arithmetically requires a lower second half, and management named the number.

"We are guiding the second half at 35%. Incrementals are really across the company, that puts the full company to 40% for the full year. We still think that, that's best-in-class when you look at what's going on across the environment. We're really happy to see the industrial businesses pivot to positive organic growth. Those numbers are a little bit muted still. So I think our guide is unchanged when it comes to what we think is best-in-class on incrementals."
— Todd Leombruno, Chief Financial Officer

This is the same framework management held to in November, when the CFO declined to reset the 30% to 35% long-term model and volunteered that incremental math flatters when the sales base is barely growing. The base is now growing at 6.6% organic, and the incremental has fallen 29 points.

Assessment: This is the most important number in the print and it cuts against the bull case. The denominator effect the CFO described in November is now working in reverse, exactly as he said it would. A 35% second-half guide is not a conservative placeholder; it is the top of the stated long-term model. The company is telling you that as volume normalizes, conversion normalizes with it. That is the ceiling on the operating-leverage argument, and it arrived one quarter after we underwrote the argument.

8. The Fourth-Quarter Shape Nobody Explained

The March quarter is guided to roughly $5.4 billion of sales, 5% organic growth, a 27.0% adjusted segment operating margin and $7.75 of adjusted EPS. With the first half at $14.87 and the full-year midpoint at $30.70, that leaves roughly $8.08 implied for the June quarter.

Set against the year-ago comparisons, the implied trajectory is a sharp deceleration: adjusted EPS grew 16.7% in the first half, is guided to grow 11.7% in March, and is implied to grow roughly 5.1% in June. Asked directly why the fourth quarter looked light, management pointed to the absolute level rather than the growth rate.

"When I look at what we have laid out here for the fourth quarter, every single number is an all-time record. The fourth quarter is normally our strongest quarter of the year."
— Todd Leombruno, Chief Financial Officer

Assessment: Both statements are true and neither answers the question. The June quarter will be a record in dollars and will show the slowest growth of the year, because the prior-year comparison is the hardest and the incremental assumption is the lowest. Given Parker's record of setting quarters low and clearing them, we would expect the actual to land above the implied. But the implied is the number in the guide, and anyone paying 30.9x is paying for the first half's growth rate, not the fourth quarter's.

9. Capital Allocation Shifts Without Being Discussed

Payments for common shares in the cash flow statement totalled $667M for the first half, of which $522M fell in the September quarter. The December quarter therefore accounted for roughly $145M, a reduction of more than 70% sequentially, in a quarter that also carried $228M of dividends. Diluted shares fell only 0.3 million sequentially, to 128.1 million.

The timing is not coincidental. Parker announced a $9.25 billion cash acquisition on November 10, committed $7.75 billion of delayed-draw term financing on December 10, and slowed repurchase in the same quarter. Cash flow itself was unremarkable, with first-half free cash flow flat year over year at $1,461M against 14.7% growth in adjusted net income.

"Just to note here, in the first half, there's a slight drag from working capital and the timing of some tax payments. We expect that to be a first half only issue. I think everyone knows this, but as a reminder, our free cash flow is second half weighted. We remain committed to free cash flow conversion of greater than 100% for the year."
— Todd Leombruno, Chief Financial Officer

Assessment: The share-count tailwind contributed $0.16 of the quarter's $1.12 of adjusted EPS growth, and it is being switched off to fund a deal. That is a defensible allocation choice and it is also a real reduction in the forward EPS algorithm, which we have taken through our FY27 estimate. Free cash flow conversion below 100% in the first half is normal for Parker and the full-year raise to $3.2 billion to $3.6 billion is a genuine increase, but flat first-half free cash flow against a 15% increase in adjusted earnings is the one line that did not participate in the quarter.

10. Price, Cost and Tariffs Remain Undisclosed

Parker does not disclose pricing, and held that line again through two separate lines of questioning: one on commodity inflation and input costs, one on the annualized tariff expense absorbed in calendar 2025.

"With some of these commodity prices, Scott, we're handling this like we have any other inflation or issues that come about. That pricing muscle is strong. And we've had a long history here of being able to handle these things."
— Jennifer Parmentier, Chairman and Chief Executive Officer

On tariffs the answer was more explicitly a refusal.

"The tariffs obviously have been pretty volatile. I don't want to make any predictions on what's going to happen with tariffs, or what has happened with tariff. I would just tell you, rest assured that we haven't covered. You have not heard us call out any negative impact from tariffs. You look at these margins, these margins are all-time records."
— Todd Leombruno, Chief Financial Officer

Assessment: The policy is consistent and consistently applied, and the margin record is a reasonable rebuttal to the concern. It remains the case that an outsider cannot verify whether a 6.6% organic quarter is 5 points of volume and 1.5 of price or the reverse, and those are different-quality quarters. The distribution channel growing organically is the closest available cross-check, and it points toward volume.

11. The Decade Question: Where Is the Volume?

The most substantive challenge of the call was not about the quarter. It observed that Parker's organic growth has averaged roughly 2% a year over the last decade, that North American Industrial has averaged about 1.5 points, and that once price is netted out the implied volumes have been flat to down across the entire period. Management's answer was that the comparison is not valid because the portfolio is not the same company.

"When we look at what we are doing in North America, first of all, it's hard to look at the company over the last decade because the portfolio has changed tremendously. When you look at the three acquisitions where you look at where our growth has been way more engineered materials, way more filtration and a heck of a lot more aerospace and defense within those industrial businesses, both in North America and international."
— Todd Leombruno, Chief Financial Officer

Assessment: The portfolio defence is fair, and the FY26 guide of 4% to 6% is genuinely inside the long-term target for the first time in three years. But the question identifies the load-bearing assumption in any Parker bull case at 30 times earnings: that this company can grow volume through a cycle, not just price and margin. Ten years of evidence say the growth has come from portfolio and conversion. This year is the first test of the other claim, and one good half does not settle it.

Guidance & Outlook

Parker raised fiscal 2026 guidance across sales, margin, EPS and free cash flow, and lifted the underlying organic assumption for every reported business and for two of six market verticals.

Organic Growth by Market Vertical

Parker guides organic growth for six market verticals that together represent more than 90% of company revenue. Two moved up this quarter and four did not, against three that moved in September.

Off-highway is the one to note, because it has now been raised twice: from a low-single-digit decline in the initial August plan, to neutral in November, to positive low single digit now, on construction and mining strength while agriculture stays under pressure. Transportation remains the year's designated problem, with no truck original-equipment recovery assumed and only aftermarket offset.

Organic Growth by Business

Where the Raise Actually Lands

Implied quarter-over-quarter ramp: the March quarter is guided to $7.75 of adjusted EPS on roughly $5.4 billion of sales, 5% organic growth and a 27.0% adjusted segment operating margin. Adding the $14.87 delivered in the first half gives $22.62 through nine months, which is 73.7% of the $30.70 midpoint and leaves roughly $8.08 implied for June. Against the prior-year quarters, that is 11.7% adjusted EPS growth in March and 5.1% in June, following 16.7% in the first half.

Decomposing the $0.70 raise: $0.55 is the Q2 actual against the $7.10 guided. The remaining $0.15 is the second half, which moves from an implied $15.68 to $15.83. Every revenue assumption in the plan went up and the earnings assumption for the back half barely moved, which locates the conservatism precisely: it is now in the margin line, and management has told us the margin line is guided to a 35% incremental.

Street at: consensus entering the print sat close to the old guide at $7.16 for the quarter, so the $30.70 midpoint moves the FY26 number up roughly 2% to 3%. The stock rose 3.5% on the day and has risen 13.7% since the November print. The multiple, not the estimate, has done the work.

Guidance style: still conservative, and measurably less so. Parker guided the September quarter to $6.51 and delivered $7.22, a 10.9% overshoot. It guided December to $7.10 and delivered $7.65, a 7.7% overshoot. Two data points do not make a trend, but the second-half incremental guide of 35% is a specific, quantified constraint that did not exist in November, and it caps how much a third overshoot can be worth.

Analyst Q&A Highlights

Twelve questioners were taken inside the one-hour slot. The dominant line of questioning was not whether the quarter was good but whether the improvement compounds: how much of the beat flows to the second half, when an eight-quarter gap between orders and sales converts, and whether a decade of roughly 2% organic growth tells you something the last two quarters do not. The Filtration Group acquisition drew little attention, and no question at all on financing.

How little of the second-quarter beat flows into the second half

The central question of the call, asked directly. The December beat was $0.55 against the company's own guide and the full-year midpoint moved $0.70, leaving $0.15 for two remaining quarters. The same question carried a second part on why the full-year North American margin implies a step down from the September print. Management answered the margin half precisely and left the flow-through half to the arithmetic.

Q: "I want to talk about the 2Q performance, which obviously was better and then how that corresponds to the full year guidance increase. It doesn't seem like you assume much of the 2Q goodness into the second half."
— Amit Mehrotra, UBS

A: "So there's nothing about the North American margin other than Q2 mix was not as favorable as Q1. That's all that's there. Listen, Q2 is a record for us, 80 basis points of margin expansion, 52% incrementals. The team is performing very well. And for we increased the margin to 26%. So we took that up. And for the second half, we're not reducing the North America margin."
— Jennifer Parmentier, Chairman and Chief Executive Officer

Assessment: The margin answer is complete and checks out; the CFO followed with a second-half North American margin of roughly 26.5%, which would be an all-time record and puts the full year up 80bps. The flow-through half was not addressed, and it is the half that matters for anyone modelling FY27 off this base. This is the second consecutive quarter in which a beat has been banked rather than extended, and the second in which management has declined to characterize why.

Whether a decade of flat volume tells you more than two good quarters

The most substantive challenge of the call went past the quarter entirely, arguing that once price is netted out of a decade averaging roughly 2% organic growth, Parker's implied volumes have been flat to down, and that at some point price and margin get harder without through-cycle volume. Management did not concede the premise, redirecting to the portfolio transformation and to the current guide sitting inside the long-term target.

Q: "If I just look at Parker's organic growth over the last decade, it's basically averaged a couple of percent per year for the entire company. In fact, North American Industrial has been 1.5 points. And when you incorporate price, it's just the implied volumes are actually down over the last decade. I guess my first question is, do you agree with that observation?"
— Amit Mehrotra, UBS

A: "The company has never been more focused on organic growth. We have a long-term target of 4% to 6%. We are guiding 4% to 6% this year. So we were right at our target. It has been 2-plus years of choppiness in the industrial markets. So I would tell you the company has never been more aligned on organic growth. And I'm really proud that we're able to generate these record margins in a not-so-great organic growth environment."
— Todd Leombruno, Chief Financial Officer

Assessment: The portfolio point is legitimate and the FY26 guide genuinely sits inside the 4% to 6% long-term target for the first time in years. What the exchange exposed is that the entire re-rating case rests on volume growth Parker has not demonstrated over a full cycle, in a business where the demonstrated skill has been acquisition and conversion. That is a fair thing to pay a premium for. It is a harder thing to pay a 30-times premium for.

Orders have outpaced sales for eight straight quarters

A recurring line of questioning on the call concerned the widening gap between bookings and shipments, framed here as a run without precedent in the questioner's coverage history. Management did not dispute the observation and declined to put a timeline on conversion, attributing the gap to a structurally longer-cycle portfolio.

Q: "But I'm also just observing that orders have outpaced sales now for 8 quarters, which I've never seen that long of a run. So maybe you could just speak to, is it reasonable to think that those do reconnect at some point in time where there's just that much more long-cycle stuff in the backlog, and obviously, at some point, things will cycle and they'll cross over."
— Jeffrey Sprague, Vertical Research Partners

A: "I mean, we're clearly a longer-cycle business today than we have been in the past. But it is hard to put a figure on conversion timing as it really is determined by the customer delivery schedule."
— Jennifer Parmentier, Chairman and Chief Executive Officer

Assessment: This is the bull case and the bear case in one exchange. Eight quarters of orders exceeding sales is either a large stored-up revenue conversion or evidence that the order metric has stopped predicting revenue for a portfolio this long-cycle. Management's follow-on point, that the backlog is improving visibility and allowing level-loaded operations, is the honest middle: the orders are real and they are worth more as a margin input than as a revenue forecast.

Why Aerospace margin steps down in the second half after two quarters above 30%

Aerospace has now printed 30.0% and 30.2% adjusted segment operating margin in consecutive quarters, and the full-year guide implies a step down. The question asked what mix dynamic drives it. Management pointed to spares and repairs volume, the same explanation offered in November, and declined to build it into the forward plan.

Q: "Like the Aero business has been doing great. Margins were above 30% in the first half the guidance implies as a step down in the second half? Just anything we need to be aware of from a mix standpoint, and why they would step down in 2H?"
— Joseph Ritchie, Goldman Sachs

A: "We called out high spares and repairs in Q2. Those are great. The business is high. It's hard to predict that going forward. So we've not put that into our forward guide there. But I would tell you, the activity is robust. The team is doing a great job converting serving our customers and you look at those margins that we're forecasting. It's still showing 60 basis points improvement from prior year, and it's high 29%, mid- 29.5% type range."
— Todd Leombruno, Chief Financial Officer

Assessment: A guide that excludes a favourable item management cannot forecast is the correct way to build a plan, and it is also the reason Aerospace has beaten its own margin guide two quarters running. The useful disclosure is the 60bps of year-over-year improvement embedded in the second half, which is the durable number. We model Aerospace above the guide and would treat a genuine step to 29.5% as the surprise rather than the base case.

Whether 40%-plus incremental margins become the new model

The same question was asked in November and asked again here, with an extra quarter of evidence behind it. The answer this time carried a specific number that the November answer did not: the second half is guided at 35%, the top of the long-term model.

Q: "you've continued to generate over 40% incremental margin. I know you've said you're still sort of guiding at 30% to 35%. But as you look forward, how long before after this good performance, do you say to yourself like you can do over 40%. And when you talk about price versus cost, is it better pricing? Is it execution? What's sort of driving this performance?"
— Adam Farley, Citigroup

A: "We are guiding the second half at 35%. Incrementals are really across the company, that puts the full company to 40% for the full year. We still think that, that's best-in-class when you look at what's going on across the environment. We're really happy to see the industrial businesses pivot to positive organic growth. Those numbers are a little bit muted still. So I think our guide is unchanged when it comes to what we think is best-in-class on incrementals."
— Todd Leombruno, Chief Financial Officer

Assessment: This is the exchange that moved our rating. Management has now put a number on the deceleration rather than describing it in the abstract, and the number is the top of the stated model. Combined with the observed compression from 73% to 44%, the operating-leverage argument that carried our November Outperform has a defined ceiling and management is the one defining it. Note also the question's second half, on price versus execution, which went entirely unanswered.

Whether the international guide is conservative after a 4.6% organic quarter

International organic growth of 4.6% is guided back to 2% in the March quarter on comparisons that do not get harder. The question probed whether that reflects conservatism or a specific dynamic. Management gave the specific dynamic without hesitation.

Q: "I think if you sort of do the math, it just seems that sequentially the growth is going to slow down to 2% the midpoint in the third quarter. And then I think the guide sort of implies it stays there in the fourth quarter. And I think you sort of alluded to large projects. just thinking that the comp is similar from second quarter to third quarter, even easier in a 2-year stack, we're being conservative, or is there sort of specific dynamics taking place in international in 3Q or 4Q."
— Andrew Obin, Bank of America

A: "it was really they did benefit in Q2 from the timing of some large project shipments. And that was primarily power gen and commercial HVAC filtration and that was in EMEA. And that it kind of aligns with some of the choppiness of the orders from the prior year. So those aren't going to repeat in Q3. So we do forecast 2% and that's based on a continued gradual industrial recovery."
— Jennifer Parmentier, Chairman and Chief Executive Officer

Assessment: A direct, verifiable answer that names the item, the vertical and the region, and that costs management the benefit of the doubt on a good quarter. It is the right disclosure and it is also a reminder that the International recovery is thinner than the print suggests. The CFO's follow-on framing, that the full-year International guide has doubled from 1% to 2%, is the fairer way to score the business than either the 4.6% quarter or the 2% guide.

Confidence in the Filtration Group synergy number before ownership

The only question on the largest acquisition in the company's history concerned synergies. Management expressed confidence, grounded it in diligence work, and volunteered that no revenue synergies are in the plan.

Q: "Wanted to follow up on Filtration Group. I imagine the teams are already getting a running start on some of the integration and preplanning. Any early observations on confidence around cost synergies? And then as you've been mapping the combination, any early view on the sales synergy side?"
— Brett Linzey, Mizuho

A: "So we are very confident in our ability to deliver that $220 million in synergies by the end of year 3. And part of our diligence process was several plant visits, and that's what gives us that confidence."
— Jennifer Parmentier, Chairman and Chief Executive Officer

On revenue synergies the answer was explicit: "We didn't model any revenue synergies, but we feel that there's opportunities to utilize the customer relationships that we both have to deliver value to customers."

Assessment: Excluding revenue synergies from the deal model is the conservative and correct choice, and it is consistent with how Parker has underwritten CLARCOR, LORD and Meggitt. The more striking feature of the exchange is what surrounds it: one question, on synergies, on a $9.25 billion transaction, with nothing asked about the financing, the pro-forma leverage, the regulatory path, or what happens to capital returns during a six-to-twelve-month pendency. That is a gap in the Street's attention, not in management's disclosure.

Why the implied fourth quarter looks light

The implied June quarter carries the slowest growth of the fiscal year despite the easiest sequential setup. The question asked whether anything mechanical explained it. The answer redirected to absolute records and to the historical pattern of the fourth quarter being the strongest of the year.

Q: "And then just lastly, on the fourth quarter, being a bit below consensus. And anything to call out there mechanically as to why the fourth quarter is, I guess, just a little bit weaker than what we would have thought."
— Steve Tusa, JPMorgan

A: "When I look at what we have laid out here for the fourth quarter, every single number is an all-time record. The fourth quarter is normally our strongest quarter of the year. We are forecasting fourth quarter to be the strongest quarter of the year again."
— Todd Leombruno, Chief Financial Officer

Assessment: The answer is true and non-responsive. Records in dollars are guaranteed by a growing company; the question was about the growth rate, which the guide implies decelerates from 16.7% in the first half to roughly 5% in the fourth quarter. Given the second-half incremental guide of 35%, the deceleration is explained by the plan's own assumptions rather than by demand. That is a reason to expect an overshoot, and also a reason not to capitalize the first half's growth rate into a terminal multiple.

What They're NOT Saying

1. No pro-forma leverage figure for Filtration Group, and no one asked: Parker committed to $7.75 billion of delayed-draw term loans on December 10, seven weeks before this call, and the word financing did not come up. On our estimate the deal takes net debt from $9.4 billion to roughly $18.7 billion and leverage to roughly 3.0x against a stated 2.0x target. That is the single largest change to the company's financial profile in a decade and it went undiscussed.
2. No quantification of Filtration Group accretion: the deal is described as accretive to adjusted EPS with no year, no magnitude and no interest-rate assumption. For a transaction equal to roughly 7.6% of Parker's market capitalization, "accretive" without a number is not a modelling input.
3. The buyback slowdown went unmentioned: payments for common shares fell to roughly $145M in the December quarter from $522M in September. That is a decision with a $0.16-per-quarter earnings footprint and it was neither disclosed as a decision nor asked about.
4. Price is still not disclosed: asked once on commodity inflation and once inside the incrementals question, management answered both times with margin outcomes rather than decomposition. The quality of a 6.6% organic quarter remains unverifiable from the outside.
5. Tariff expense declined to be quantified: asked for the annualized absorbed tariff cost in calendar 2025 and whether lapping it creates a second-half-2026 incremental tailwind, the answer was an explicit refusal to make predictions. The question was about a past cost, not a future one.
6. Still no new long-term margin anchor: the FY29 27% adjusted segment margin target now sits at the bottom of this year's guide range of 27.0% to 27.4%. In November management declined to replace it when asked. This quarter nobody asked, and the target quietly stopped being a target.
7. Flat first-half free cash flow against 15% earnings growth: first-half free cash flow of $1,461M was $2M below the prior year while adjusted net income grew 14.7%. Management attributed the drag to working capital and tax timing and called it a first-half-only issue, without a bridge. The full-year conversion commitment is unchanged, so the second half now has to do more.
8. The fourth-quarter growth rate: the guide implies roughly 5% adjusted EPS growth in June against 17% delivered in December. Asked directly, management answered with absolute records. Neither the comparison base nor the 35% second-half incremental was named as the cause, though both are.

Market Reaction

• Pre-print setup: the shares closed at $916.27 on January 28, up 4.2% year to date, up 3.1% over the trailing thirty days and up 37.6% over the trailing twelve months. That close sat just below the top of the trailing 52-week closing range of $517.23 to $945.29, so Parker entered the print near a closing high with a full year of gains banked.
• Reaction session (January 29, a before-the-open report): the stock was indicated up roughly 4.7% pre-market near $950, opened at $936.54 for a 2.2% gap, traded between $933.05 and $965.00, and closed at $948.40, up 3.5% or $32.13. The intraday low held 1.8% above the prior close, so the gap was never filled.
• Volume: 1.2 million shares against a 30-day average of 0.6 million, roughly 2.1 times normal.
• Relative move: the S&P 500 was fractionally lower on the session at -0.1%, so Parker outperformed the index by roughly 3.6 points.

The reaction was proportionate this time, which is itself the story. Full-year adjusted EPS guidance rose 2.3% at the midpoint and the stock rose 3.5%, closing at a new high. Compare that to November, when a 3.8% guidance raise produced a 7.8% single-session gain on a day the index fell 1.1%. The re-rating happened in the September quarter; the December quarter was paid for at close to face value.

What the market paid for. The incremental information in this print was breadth and durability rather than surprise. Europe turning positive, all three technology platforms growing, distribution growing, the industrial backlog inflecting: each of those extends the duration of the recovery the market repriced in November. The absence of an outsized move suggests the market had already granted the duration and was checking the work.

The setup is the problem. The stock entered this print having gained 13.7% since the November close of $834.15, against a full-year earnings guide that moved 2.3% over the same span. Roughly eleven of those fourteen points came from multiple expansion rather than from the estimate. At $948.40 the shares trade at 30.9 times the midpoint of a guide the company has just told you carries 35% incrementals in the back half, and the November close was already 27.8 times.

What did not happen. No fade into the close, but no acceleration either: the stock finished 1.7% below its intraday high on 2.1 times normal volume, which is orderly participation rather than the institutional accumulation signature of the November session. The pre-market indication of roughly 4.7% was the day's high-water mark for enthusiasm.

Street Perspective

Debate: Is $9.25 billion for Filtration Group a good use of the balance sheet?

Bull view: The bull case being made on the Street is that Parker has earned the benefit of the doubt on large acquisitions, having re-rated CLARCOR, LORD and Meggitt through the Win Strategy, and that filtration is the platform where its integration playbook works best. At 13.4 times post-synergy EBITDA for a business with a higher aftermarket mix than Parker's own, this is a quality-improving deal that raises the through-cycle multiple the whole company deserves.

Bear view: The bear camp points to 19.6 times pre-synergy as a full price paid at the top of the cycle and the top of Parker's own multiple, notes that the $220 million of synergies is not realized until the end of year three, and observes that the deal takes leverage to roughly 3.0 times against a stated 2.0 times target while suspending the buyback that has been contributing meaningfully to EPS growth. A high-single-digit cash return on invested capital by year five is not a hurdle rate that clears the company's own cost of equity quickly.

Our take: The strategic logic is the strongest part of this deal and the price is the weakest. We would not have paid 19.6 times, and we note that management's own criteria are stated in synergized terms, which is where every acquirer's arithmetic looks best. The relevant judgment is not whether it works but when: on our framework the transaction is roughly EPS-neutral in its first full year, meaningfully accretive by year three, and dilutive to return on capital until the synergies land. That is a fine trade for a ten-year holder and a poor one for a twelve-month rating.

Debate: Have incremental margins peaked?

Bull view: The optimistic argument is that 44% is still 900bps above the top of the long-term model, that every business set a record margin for the second consecutive quarter, and that the 35% second-half guide is the same institutional conservatism that produced a 73% incremental in September and a 52% incremental in North America this quarter. Parker has under-guided conversion for two years running.

Bear view: The skeptical read is that the CFO explained the mechanism himself in November: incremental math flatters on a flat revenue base. The base is now growing 6.6% organically and the incremental has fallen 29 points in a single quarter. That is not conservatism, it is the arithmetic working as described, and the second-half guide of 35% is management confirming it.

Our take: The bear has the better of this one, and it is the reason for the downgrade. Two quarters ago the incremental was an unmodelled source of upside; today it is a guided number at the top of the stated model, and it moved there without a demand deterioration. We continue to expect Parker to beat 35%, because it always does. We no longer think beating 35% is worth three turns of multiple.

Debate: Is the industrial recovery finally broad enough to underwrite?

Bull view: The bull case is that this is the cleanest industrial print of the cycle: three technology platforms positive together for the first time since June 2023, distribution growing organically, Europe positive, the industrial backlog inflecting, orders at 9% against a 5% organic plan, and channel inventory that was described as at a trough one quarter ago with the restock still ahead.

Bear view: The bear camp notes that the International beat came from non-repeating EMEA project shipments management named on the call, that North America's order jump was driven by multi-year defense bookings that convert over years, and that the in-plant capital spending recovery is still being characterized as gradual and selective seven quarters after the trough. The company's own full-year North American organic assumption is still only 2.5%.

Our take: The bulls are right about the direction and the bears are right about the pace. Our November thesis that the cycle was inflecting has been confirmed twice, and we would not argue it now. The change is that the recovery is no longer a private observation available to anyone reading the order book against the plan. It is in the guide, it is in the vertical revisions, and it is in the price.

Debate: Does 31 times forward earnings survive a normalizing incremental?

Bull view: The argument for the multiple is that Parker is no longer an industrial. Aerospace is a third of revenue at a 30% margin with a record $8 billion backlog, the portfolio is being deliberately shifted toward aftermarket and long-cycle exposure, free cash flow conversion is committed above 100%, and the Filtration Group deal accelerates all of it. Quality of that composition re-rates once and stays re-rated.

Bear view: The bear case is arithmetic. At 30.9 times a guide midpoint growing 12.3%, against a second half guided to 35% incrementals, a buyback being switched off and leverage rising toward 3.0 times, the shares discount the recovery, the margin and the deal simultaneously. Any one of those disappointing leaves the multiple as the only support, and the multiple is at an all-time high.

Our take: We were on the bull side of this debate in November at 27.8 times, and the argument then was explicitly that no further re-rating was required to clear the index. Three turns later that argument no longer holds. We are not calling for a de-rating and our base case assumes none. We are saying that at 27.9 times our FY27 estimate, the twelve-month total return we can defend is roughly 1%, and that is what a Hold is.

Model Update

Our November model was set at initiation. The table below moves it for the December quarter, the raised guide and the changed capital-allocation assumption.

Valuation

At the January 29 close of $948.40 on 128.1 million diluted shares, Parker carries a market capitalization near $121.5 billion and, adding $9.4 billion of net debt, an enterprise value near $130.9 billion. That is 30.9 times the FY26 adjusted EPS guide midpoint of $30.70, 34.7 times FY25's actual adjusted EPS of $27.33, and roughly 23 times our FY26 adjusted EBITDA estimate of $5.7 billion. Free cash flow yields 2.8% on the $3.4 billion guidance midpoint and the dividend yields 0.8%.

The comparison that matters is against our own November work. At the post-print close of $834.15 the shares traded at 27.8 times the then-current guide midpoint of $30.00. The guide has since risen 2.3% and the shares 13.7%.

Our FY27 estimate builds from our FY26E of $31.25 and excludes Filtration Group, which had not closed as of this report and for which management has published no accretion figure:

Two changes from November's bridge are worth naming. We have cut the assumed incremental from 38% to 37% to reflect the guided second-half step to 35%, and we have cut the buyback contribution from roughly 1.5% of shares to roughly 0.5%, because Parker slowed repurchase to roughly $145M in the December quarter and has $9.25 billion of consideration to fund. Those two changes cost about $0.40 of FY27 earnings and are the reason our FY27 estimate rises only $0.25 despite a $0.50 increase to FY26.

On Filtration Group specifically, the framework we carry outside the base case is this: roughly $470 million of acquired adjusted EBITDA against roughly $460 million of annual pre-tax financing cost at current rates on $9.25 billion, which nets to approximately break-even before synergies and modestly accretive once the first tranche of the $220 million lands. By the end of year three, with the full synergy run-rate, the deal contributes on the order of $1.00 per share. That is a real addition to FY29 and beyond. It contributes close to nothing inside a twelve-month rating horizon, and it removes the buyback in the meantime.

Valuation impact: we set a twelve-month target of $952, which applies 28.0 times to our FY27E adjusted EPS of $34.00. That multiple is slightly above the 27.5 times we used in November and slightly below where the shares closed on this print relative to FY27, so the target assumes no further re-rating and no de-rating. From $948.40 that implies 0.4% price appreciation and roughly 1.2% total return including the dividend.

Thesis Scorecard Post-Earnings

The pillars below are the ones established at initiation in November and carried in our thesis of record. They are scored as stated, not restated.

Overall: the operating thesis strengthened and the investment thesis weakened. Four of the seven standing pillars moved in our favour on the fundamentals, and the two that moved against us are the two that determine a twelve-month rating: the conversion rate that produced the earnings upside is guided back to the long-term model, and the multiple has absorbed the recovery we were waiting to be recognized. Adding the acquisition as a new risk point, the pillar balance no longer supports Outperform.

Action: downgrade to Hold. We would hold existing positions and would not add at these levels. Parker remains the highest-quality industrial compounder in our coverage and the business is executing better than it was one quarter ago; the entry price is simply no longer one we can defend. We would revisit on either a de-rating toward 26 times forward earnings, which is roughly $884 on our FY27 estimate, or evidence that second-half incrementals are running materially above the guided 35%. The next checkpoint is the March quarter, where we will grade four commitments: adjusted EPS of $7.75 on a 27.0% adjusted segment margin and 5% organic growth, second-half incrementals of 35%, North American second-half margin of roughly 26.5%, and whether Filtration Group clears regulatory review inside the six-to-twelve-month window.